The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analy...

por Li, Edward, Schroader, Bridgette Kanz, Campbell, David, Campbell, Kim, Wang, Weijia
Publicado 2021

The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia

por Spargo, Andrew, Yost, Christopher, Squires, Patrick, Raju, Aditya, Schroader, Bridgette, Brown, Joshua D
Publicado 2021

Economic and clinical outcomes of pegfilgrastim via prefilled syringe vs on-body injector: a real-world data analysis

por McBride, Ali, Campbell, Kim, Li, Edward, Schroader, Bridgette, Campbell, David, Wang, Weijia
Publicado 2021

Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States

por Kota, Vamsi, Ogbonnaya, Augustina, Farrelly, Eileen, Schroader, Bridgette Kanz, Raju, Aditya, Kristo, Fjoralba, Dalal, Mehul
Publicado 2022

Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant

por Ailawadhi, Sikander, Ogbonnaya, Augustina, Murty, Sharanya, Cherepanov, Dasha, Schroader, Bridgette Kanz, Romanus, Dorothy, Farrelly, Eileen, Chari, Ajai
Publicado 2022

Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer

por Aapro, Matti S., Chaplin, Stephen, Cornes, Paul, Howe, Sebastian, Link, Hartmut, Koptelova, Natalia, Mehl, Andrea, Di Palma, Mario, Schroader, Bridgette Kanz, Terkola, Robert
Publicado 2023